Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 2
1952 1
1960 1
1962 2
1964 2
1966 1
1967 3
1968 3
1969 5
1970 1
1971 2
1972 3
1973 2
1975 7
1976 10
1977 6
1978 4
1979 5
1980 11
1981 4
1982 7
1983 4
1984 3
1985 5
1986 13
1987 20
1988 29
1989 16
1990 23
1991 29
1992 29
1993 43
1994 38
1995 32
1996 44
1997 43
1998 55
1999 56
2000 49
2001 61
2002 50
2003 81
2004 73
2005 70
2006 102
2007 87
2008 96
2009 91
2010 94
2011 78
2012 69
2013 91
2014 178
2015 172
2016 192
2017 193
2018 195
2019 203
2020 218
2021 251
2022 246
2023 214
2024 111

Text availability

Article attribute

Article type

Publication date

Search Results

3,431 results

Results by year

Filters applied: . Clear all
Page 1
Memorial: William E. O'Brien, Ph.D.
Elsea SH, Beaudet AL. Elsea SH, et al. Mol Genet Metab. 2024 Mar 25;142(1):108435. doi: 10.1016/j.ymgme.2024.108435. Online ahead of print. Mol Genet Metab. 2024. PMID: 38531185 No abstract available.
Response to letter from Dr M. D. O'Brien.
Lawson I, Cooke R. Lawson I, et al. Occup Med (Lond). 2021 Aug 20;71(4-5):235-236. doi: 10.1093/occmed/kqab062. Occup Med (Lond). 2021. PMID: 34416005 No abstract available.
The biology of chronic myeloid leukemia.
Faderl S, Talpaz M, Estrov Z, O'Brien S, Kurzrock R, Kantarjian HM. Faderl S, et al. N Engl J Med. 1999 Jul 15;341(3):164-72. doi: 10.1056/NEJM199907153410306. N Engl J Med. 1999. PMID: 10403855 Review. No abstract available.
Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia.
Hochhaus A, Larson RA, Guilhot F, Radich JP, Branford S, Hughes TP, Baccarani M, Deininger MW, Cervantes F, Fujihara S, Ortmann CE, Menssen HD, Kantarjian H, O'Brien SG, Druker BJ; IRIS Investigators. Hochhaus A, et al. N Engl J Med. 2017 Mar 9;376(10):917-927. doi: 10.1056/NEJMoa1609324. N Engl J Med. 2017. PMID: 28273028 Free PMC article. Clinical Trial.
A network perspective for sustainable agroecosystems.
Allen WJ, Bufford JL, Barnes AD, Barratt BIP, Deslippe JR, Dickie IA, Goldson SL, Howlett BG, Hulme PE, Lavorel S, O'Brien SA, Waller LP, Tylianakis JM. Allen WJ, et al. Trends Plant Sci. 2022 Aug;27(8):769-780. doi: 10.1016/j.tplants.2022.04.002. Epub 2022 Apr 29. Trends Plant Sci. 2022. PMID: 35501260 Review.
Progress in acute myeloid leukemia.
Kadia TM, Ravandi F, O'Brien S, Cortes J, Kantarjian HM. Kadia TM, et al. Clin Lymphoma Myeloma Leuk. 2015 Mar;15(3):139-51. doi: 10.1016/j.clml.2014.08.006. Epub 2014 Sep 19. Clin Lymphoma Myeloma Leuk. 2015. PMID: 25441110 Free PMC article. Review.
3,431 results